Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

He added, “This works and it works quite well.” Ferring presents new phase 3b safety and effectiveness data for recurrent C. diff patients receiving Rebyota (fecal microbiota, live-jslm ...

Sixty-four more hospitals had a rate of zero, the lowest rate possible, for C. diff infections compared to CMS’ 2023 list.

A team of researchers at Columbia, Harvard and University of Minnesota has developed a gene editing technique they say could pave the way for new therapies for a host of diseases with fewer ...

When it comes to infections, most hospitals in Delaware and on the Eastern Shore of Maryland performed better than expected when it came to infections like C. diff and MRSA, two potentially ...

DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq ... Taysha in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option has an exercise price of $2.41 which ...

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment made just for him. Researchers described the case in a new study ...

That was the first of several setbacks. Surgeries that didn’t heal well. A seroma. C-diff from the antibiotics. “Everything that could go wrong seemed to go wrong,” he said. It was more than ...

PITTSBURGH (AP) — Gene Lamont hadn’t been in uniform since 2017, his last year as the Detroit Tigers’ bench coach. And it had been 25 years since he managed the Pittsburgh Pirates.